Combination and interaction of ageing parameters on single lap shear adhesive joints

Autor: Fevery, S., Latré, S.K., Vandepitte, D., Debruyne, S., Hallez, H.

Publikováno v: In International Journal of Adhesion and Adhesives December 2021 111

The (cost-)effectiveness of early intervention (MBT-early) versus standard protocolized treatment (CBT) for emerging borderline personality disorder in adolescents (the EARLY study): a study protocol for a randomized controlled trial.

Autor: Remeeus MGA; Behavioural Science Institute, Radboud University, Thomas Van Aquinostraat 4, Nijmegen, 6525GD, The Netherlands. melissa.remeeus@deviersprong.nl.; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands. melissa.remeeus@deviersprong.nl., Clarke SL; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychological disorders and Somatic diseases (CoRPS), Tilburg University, Warandelaan 2, Tilburg, 5037AB, The Netherlands., Feenstra DJ; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands.; Department of Medical Psychology and Psychotherapy, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands., Van Eeren H; Department of Medical Psychology and Psychotherapy, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands., Smits ML; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands., Debruyne S; Mentaal Beter, Steijnlaan 12, Hilversum, 1217JS, The Netherlands., Kouijzer MEJ; GGz Breburg, Poolseweg 190, Breda, 4818CG, The Netherlands., Luyten P; Faculty of Psychology and Educational Sciences, University of Leuven, Dekenstraat 2, Leuven, 3000, Belgium.; Research Department of Clinical, Educational, and Health Psychology, University College London, Gower Street, London, WC1E 6BT, UK., Scholte RHJ; Behavioural Science Institute, Radboud University, Thomas Van Aquinostraat 4, Nijmegen, 6525GD, The Netherlands., Hutsebaut J; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychological disorders and Somatic diseases (CoRPS), Tilburg University, Warandelaan 2, Tilburg, 5037AB, The Netherlands.

Publikováno v: Trials [Trials] 2024 Apr 15; Vol. 25 (1), pp. 261. Date of Electronic Publication: 2024 Apr 15.

Structural health monitoring of Cerasol® roof tiles with embedded FBG sensors.

Autor: Fevery, S., Van Massenhove, K., Debruyne, S., Vandepitte, D., Hallez, H.

Publikováno v: Journal of Adhesion; 2023, Vol. 99 Issue 11, p1857-1871, 15p

Short Flax Fibres and Shives as Reinforcements in Bio Composites: A Numerical and Experimental Study on the Mechanical Properties.

Autor: Verstraete S; Research Group ProPoliS, Department of Materials Engineering, KU Leuven Campus Bruges, Spoorwegstraat 12, 8200 Bruges, Belgium., Buffel B; Research Group ProPoliS, Department of Materials Engineering, KU Leuven Campus Bruges, Spoorwegstraat 12, 8200 Bruges, Belgium., Madhav D; Surface and Interface Engineered Materials, Department of Materials Engineering, KU Leuven Campus Bruges, Spoorwegstraat 12, 8200 Bruges, Belgium., Debruyne S; Research Group M-Group, Department of Mechanical Engineering, KU Leuven Campus Bruges, Spoorwegstraat 12, 8200 Bruges, Belgium., Desplentere F; Research Group ProPoliS, Department of Materials Engineering, KU Leuven Campus Bruges, Spoorwegstraat 12, 8200 Bruges, Belgium.

Publikováno v: Polymers [Polymers (Basel)] 2023 May 09; Vol. 15 (10). Date of Electronic Publication: 2023 May 09.

A phase II study of Monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

Autor: R Galot, C Le Tourneau, E Saada-Bouzid, A Daste, C Even, P Debruyne, S Henry, S Zanetta, A Rutten, L Licitra, JL Canon, MC Kamin, ESMO annual congress 2019

Publikováno v: Annals of Oncology, Vol. 30 (suppl 5) (2019), p. l 5) (2019)

Background Patients (pts) with RM SCCHN progressing after platinum have a median overall survival (OS) of 7-8 months with nivolumab or pembrolizumab. No other drug has shown meaningful activity in this setting. HLA-E is a non-classical MHC molecule t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1493::6961ded2849deb946c22b2af9b674494
https://hdl.handle.net/2078.1/226092